Overview

Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers

Status:
RECRUITING
Trial end date:
2028-01-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to evaluate the pharmacokinetics of a one-time dosing of two F/TAF tablets over a 14-day period.
Phase:
PHASE1
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Emtricitabine
Racivir
tenofovir alafenamide